NADPH oxidase p22phox and catalase gene variants are associated with biomarkers of oxidative stress and adverse outcomes in acute renal failure.

Reactive oxygen species are important mediators of injury in acute renal failure (ARF). Although polymorphisms that affect key pro- and antioxidant enzymes might alter the susceptibility to oxidative stress-mediated injury, the use of genetic epidemiology for the study of oxidative stress-related genes has received little attention in ARF. The relationship of single-nucleotide polymorphisms in the coding region (C to T substitution at position +242) of the pro-oxidant enzyme NADPH oxidase p22phox subunit gene and in the promoter region (C to T substitution at position -262) of the antioxidant enzyme catalase gene to adverse clinical outcomes was evaluated prospectively in a cohort of 200 hospitalized patients with established ARF of mixed cause and severity. Genomic DNA was extracted from peripheral blood leukocytes and analyzed with a restriction fragment length polymorphism PCR method. Genotype-phenotype associations were characterized by measuring circulating nitrotyrosine and catalase activity. Observed and expected genotype frequencies were not significantly different, and overall baseline characteristics were not significantly different according to the various genotype groups. A genotype-phenotype association was demonstrable between the NADPH oxidase p22phox genotypes and plasma nitrotyrosine level (P = 0.06), as well as between the catalase genotypes and whole-blood catalase activity (P < 0.001). Compared with the NADPH oxidase p22phox CC genotype group, the T-allele group had a higher cumulative probability of remaining hospitalized (P = 0.03). Compared with the NADPH oxidase p22phox CC genotype, the T-allele carrier state was associated with 2.1-fold higher odds for dialysis requirement or hospital death (P = 0.01). This association persisted with 2.0- to 2.2-fold higher odds for this composite outcome after adjustment for race; gender; age; and the Acute Physiology and Chronic Health Evaluation II score (P = 0.03), the Multiple Organ Failure score (P = 0.01), or presence of sepsis (P = 0.02). The polymorphism in the gene that encodes the NADPH oxidase p22phox subunit at position +242 is associated with dialysis requirement or hospital death among patients with ARF. Larger studies are needed to confirm these relationships.

[1]  Tom Greene,et al.  Assessing kidney function--measured and estimated glomerular filtration rate. , 2006, The New England journal of medicine.

[2]  R. Ferrell,et al.  NADPH oxidase p22phox gene variants are associated with systemic oxidative stress biomarker responses to exercise training. , 2005, Journal of applied physiology.

[3]  L. Price,et al.  Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. , 2005, Clinical journal of the American Society of Nephrology : CJASN.

[4]  K. Tokunaga,et al.  Haplotype analysis of NAD(P)H oxidase p22 phox polymorphisms in end-stage renal disease , 2005, Journal of Human Genetics.

[5]  R. de Caterina,et al.  Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants , 2005, European journal of clinical investigation.

[6]  R. Atkins The epidemiology of chronic kidney disease. , 2005, Kidney international. Supplement.

[7]  J. Bertrand,et al.  Association of CAT polymorphisms with catalase activity and exposure to environmental oxidative stimuli , 2005, Free radical research.

[8]  Jonathan Himmelfarb,et al.  Spectrum of acute renal failure in the intensive care unit: the PICARD experience. , 2004, Kidney international.

[9]  Y. Ho,et al.  Mice Lacking Catalase Develop Normally but Show Differential Sensitivity to Oxidant Tissue Injury* , 2004, Journal of Biological Chemistry.

[10]  M. Goligorsky,et al.  NO bioavailability, endothelial dysfunction, and acute renal failure: new insights into pathophysiology. , 2004, Seminars in nephrology.

[11]  D. Harrison,et al.  C242T CYBA Polymorphism of the NADPH Oxidase Is Associated With Reduced Respiratory Burst in Human Neutrophils , 2004, Hypertension.

[12]  R. Turakulov,et al.  A new type 1 diabetes susceptibility locus containing the catalase gene (chromosome 11p13) in a Russian population , 2004, Diabetes/metabolism research and reviews.

[13]  B. Jaber,et al.  Cytokine gene promoter polymorphisms and mortality in acute renal failure. , 2004, Cytokine.

[14]  A. Demaine,et al.  Association of the p22phox component of NAD(P)H oxidase with susceptibility to diabetic nephropathy in patients with type 1 diabetes. , 2003, Diabetes care.

[15]  T. Maruyama,et al.  NAD(P)H oxidase p22phox Gene C242T polymorphism and lipoprotein oxidation. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[16]  N. Webster,et al.  Oxidative stress and gene expression in sepsis. , 2003, British journal of anaesthesia.

[17]  R. Poveda,et al.  Goodpasture syndrome during the course of a Schönlein-Henoch purpura. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  S. Hou,et al.  Hospital-acquired renal insufficiency. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[19]  W. Renner,et al.  NADH/NADPH oxidase p22 phox C242T polymorphism and lipid peroxidation in coronary artery disease. , 2001, Clinical physiology.

[20]  U. de Faire,et al.  Oxidative stress, human genetic variation, and disease. , 2001, Archives of biochemistry and biophysics.

[21]  U. de Faire,et al.  A common functional C-T substitution polymorphism in the promoter region of the human catalase gene influences transcription factor binding, reporter gene transcription and is correlated to blood catalase levels. , 2001, Free radical biology & medicine.

[22]  G. FitzGerald,et al.  Twenty-first century phox: not yet ready for widespread screening. , 2001, Circulation.

[23]  K. Channon,et al.  Functional Effect of the C242T Polymorphism in the NAD(P)H Oxidase p22phox Gene on Vascular Superoxide Production in Atherosclerosis , 2000, Circulation.

[24]  M. Fischer,et al.  Impact of acute renal failure on antioxidant status in multiple organ failure , 2000, Acta anaesthesiologica Scandinavica.

[25]  Y. Hayashi,et al.  Expression of NADH/NADPH oxidase p22phox in human coronary arteries. , 1999, Circulation.

[26]  R. Crystal,et al.  Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. , 1998, Human gene therapy.

[27]  R. Apsner,et al.  Fat-Soluble Vitamins in Patients with Acute Renal Failure , 1998, Mineral and Electrolyte Metabolism.

[28]  K. Kanazawa,et al.  Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. , 1998, Circulation.

[29]  Sudhir V. Shah,et al.  Oxidant mechanisms in toxic acute renal failure. , 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[30]  J. Beckman Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.

[31]  J. Hayes,et al.  Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. , 1995, Free radical research.

[32]  W. Knaus,et al.  Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. , 1992, Chest.

[33]  J. E. Carceller American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis , 1992, Critical care medicine.

[34]  W. Knaus,et al.  Multiple systems organ failure: epidemiology and prognosis. , 1989, Critical care clinics.

[35]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[36]  P. Rousseeuw Least Median of Squares Regression , 1984 .

[37]  J. Cohen,et al.  Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.

[38]  G. Berti,et al.  Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. , 1980, Clinical chemistry.

[39]  B. Jaber,et al.  Polymorphism of host response genes: implications in the pathogenesis and treatment of acute renal failure. , 2005, Kidney international.

[40]  A. Demaine,et al.  Association of the p 22 phox Component of NAD ( P ) H Oxidase With Susceptibility to Diabetic Nephropathy in Patients With Type 1 Diabetes , 2003 .

[41]  K Doqi,et al.  clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification , 2002 .

[42]  J. Mitchell,et al.  Redox imbalance in the critically ill. , 1999, British medical bulletin.